To: Jim Baker who wrote (1012 ) 1/8/1998 2:26:00 AM From: Maurice Winn Respond to of 3702
Jim, as a prospective new investor looking at this stock, I have to say your following statement is wrong, at least for me. I'm very keen to know that the management are all the good things management should be. Managers can destroy companies faster than scientists or anybody else can build them. So yes, I would pass on making the investment because of management if I thought that was the case. "Imagine you were a new investor looking at this stock. Would you pass on making the investment because of management? No, you would have no opinion of management, so that would not be a big issue either way. But you would be concerned about the looming Reg-D cap period, the burn to cash ratio, the "maybe yes, maybe no" clinical trials, and the lack of partners." Of course, the other aspects you mentioned are also vital. As are many other things. The burn to cash ratio isn't important to me though. That just sets the time when new money has to be raised but doesn't in itself affect the price of that money. Buying shares now, or at the "out of money" stage doesn't inherently affect the value of the business. Though cash flow crises are never a good way to manage something as hasty and bad decisions can be made in the heat of the moment. On sheer buying and selling action, fear and greed, market prospects and all the rest, it seems like possibly a real deal at the current price = $1.70 or something. But market capitalisation is still substantial, so existing shareholders are far from owning a zero value stock. Although most would be feeling pretty sick about their investment just now. Davis is right with this one: "(1) TCLN will not run out of money, for a price financing is always available". True enough! Maurice